Kawasaki disease: Four case reports of cardiopathy with an institutional and literature review

被引:4
作者
Ashrafi, Amir H.
Wang, Jenny
Stockwell, Christina A.
Lloyd, David
McAlvin, James B.
Russo, Pierre
Shehata, Bahig M.
机构
[1] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA 30332 USA
[2] Childrens Healthcare Atlanta, Dept Pathol, Atlanta, GA 30332 USA
[3] Childrens Healthcare Atlanta, Dept Clin Res, Atlanta, GA 30332 USA
[4] Childrens Healthcare Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
[5] Emory Univ, Dept Pathol, Atlanta, GA 30332 USA
关键词
kawasaki disease; intravenous immune globulin; vascular endothelial growth factor;
D O I
10.2350/06-10-0172.1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Kawasaki disease (KD) is a systemic vasculitis condition with a relatively unknown etiology. First described in 1967 by Tomisaku Kawasaki in Japan, KD has come to be widely diagnosed in every region of the world. The disease has a high prevalence in children ages 6 months to 5 years, particularly in those of Japanese descent. Patients often present with a high fever, rash, lymphadenopathy, and conjunctival injections, but there is no diagnostic test for KD. This paper presents data from our Kawasaki registry including 99 patients with emphasis on Kawasaki cardiopathy. Three patients died from complications of KD, and 1 patient underwent heart transplant for massive aneurysmal dilatation. The 4 explanted hearts showed a spectrum of pathological findings (acute thrombosis, vasculitis, and myocarditis), and I patient showed the long-term sequelae of vasculitis in the form of massive aneurysmal dilatation. Among the survivors, 30% showed aneurysmal dilatation. This paper reviews the most recent information regarding Kawasaki cardiopathy and underlying molecular mechanisms.
引用
收藏
页码:491 / 499
页数:9
相关论文
共 57 条
[1]   Tumor necrosis factor-α levels and promoter polymorphism in patients with Kawasaki disease in Korea [J].
Ahn, SY ;
Jang, GC ;
Shin, JS ;
Shin, KM ;
Kim, DS .
YONSEI MEDICAL JOURNAL, 2003, 44 (06) :1021-1026
[2]   Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease [J].
Biezeveld, MH ;
Kuipers, IM ;
Geisser, J ;
Lam, J ;
Ottenkamp, JJ ;
Hack, CE ;
Kuijpers, TW .
LANCET, 2003, 361 (9365) :1268-1270
[3]   Kawasaki syndrome [J].
Burns, JC ;
Glodé, MP .
LANCET, 2004, 364 (9433) :533-544
[4]   Kawasaki disease: A brief history [J].
Burns, JC ;
Kushner, HI ;
Bastian, JF ;
Shike, H ;
Shimizu, C ;
Matsubara, T ;
Turner, CL .
PEDIATRICS, 2000, 106 (02) :E27
[5]   Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan [J].
Chang, LY ;
Chiang, BL ;
Kao, CL ;
Wu, MH ;
Chen, PJ ;
Berkhout, B ;
Yang, HC ;
Huang, LM .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (02) :283-286
[6]   Circulating cardiac troponin I levels in Kawasaki disease [J].
Checchia, PA ;
Borensztajn, J ;
Shulman, ST .
PEDIATRIC CARDIOLOGY, 2001, 22 (02) :102-106
[7]   Modulating effects of mannose binding lectin genotype on arterial stiffness in children after Kawasaki disease [J].
Cheung, YF ;
Ho, MHK ;
Ip, WK ;
Fok, SFS ;
Yung, TC ;
Lau, YL .
PEDIATRIC RESEARCH, 2004, 56 (04) :591-596
[8]  
Chien YH, 2003, J FORMOS MED ASSOC, V102, P147
[9]   VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[10]   KAWASAKI SYNDROME IN WASHINGTON-STATE - RACE-SPECIFIC INCIDENCE RATES AND RESIDENTIAL PROXIMITY TO WATER [J].
DAVIS, RL ;
WALLER, PL ;
MUELLER, BA ;
DYKEWICZ, CA ;
SCHONBERGER, LB .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (01) :66-69